SCHEMBL14046253

SCHEMBL14046253

CC(C)NC(=O)c1ccccc1-c1ccc(C(C)C)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
KLRK1 P26718 2/20 0.49
MICA Q29983 2/20 0.49
RAET1L Q5VY80 1/20 0.49
TSHR P16473 1/20 0.49
SLC6A3 Q01959 3/20 0.49
SLC6A4 P31645 2/20 0.49
KCNA3 P22001 3/20 0.47
CLPP Q16740 2/20 0.45
CHRNB2 P17787 1/20 0.45
CHRNB4 P30926 1/20 0.45
CHRNA3 P32297 1/20 0.45
CHRNA4 P43681 1/20 0.45
HPGD P15428 1/20 0.44
XBP1 P17861 1/20 0.44
USP2 O75604 2/20 0.44
LMNA P02545 1/20 0.44
MAPT P10636 1/20 0.44
MCL1 Q07820 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8696620 0.87 CHRNB2 (0.59) MEN1KMT2ACLPPCHRNB2CHRNB4
SCHEMBL6797969 0.83 SLC6A3 (0.71) MEN1KMT2ATSHRSLC6A3SLC6A4
SCHEMBL29978969 0.83 SLC6A3 (0.71) MEN1KMT2ATSHRSLC6A3SLC6A4
SCHEMBL14046203 0.82 CDK4 (0.49) MEN1KMT2AKLRK1MICARAET1L
SCHEMBL9864612 0.82 MEN1 (0.50) MEN1KMT2AKLRK1MICARAET1L
SCHEMBL4741406 0.80 DHODH (0.56) MEN1KMT2AUSP2LMNAMAPT
SCHEMBL5937166 0.79 SLC6A3 (0.49) MEN1KMT2AKLRK1MICARAET1L
Hydrochloric Acid SCHEMBL5937171 0.79 DHODH (0.55) MEN1KMT2AUSP2LMNAMAPT
SCHEMBL2563193 0.79 BCAT2 (0.65) MEN1KMT2ATSHRSLC6A3SLC6A4
SCHEMBL14046209 0.78 ALDH1A1 (0.42) MEN1KMT2AKCNA3USP2MCL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249130-A1 Gut microsomal triglyceride transport protein inhibitors SIRTRIS PHARMACEUTICALS, INC. (US) 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249130-A1 Gut microsomal triglyceride transport protein inhibitors MTTP, CETP, FABP2 MEN1 3927/4885KMT2A 2256/4885KLRK1 3791/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.